Manufacture of basic pharmaceutical products · Cambridge
AstraZeneca
Astrazeneca PLC
Public limited company registered in Cambridge, classed under “Manufacture of basic pharmaceutical products” and 3 other activities.
Headline figures
FY to Dec 2025 · Group consolidated
Turnover
For subscribers
Profit after tax
$10.2bn
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
3 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| US$ | 2023 | 2024 | 2025 |
|---|---|---|---|
| Profit after tax | $10.2bn | ||
| Turnover | |||
| Net assets | |||
| Cash | |||
| Employees | |||
| Retained reserves |
Every figure for all 3 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · €
| Balance sheet | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current assets | |||
| of which cash | |||
| Creditors due within a year | |||
| Creditors due after a year | |||
| Net assets | |||
| Ratios | |||
| Profit marginProfit after tax as a share of turnover | |||
| Return on equityProfit after tax as a share of net assets | |||
| Current ratioCurrent assets for every £1 owed within a year | |||
| Cash ratioCash for every £1 owed within a year | |||
5 balance-sheet lines and 4 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-18
- SharesStatement of capital following an allotment of shares on 23 September 2026 · USD 387,763,272.75, GBP 50,000 (and 46 more like it since 9 December 2022)
- DirectorsAppointment of Wan Ling Martello as a director on 1 September 2026
- DirectorsTermination of appointment of Rene Anthony Andrada Haas as a director on 30 April 2026
- FilingResolutions (and 17 more like it since 17 May 2023)
- FilingAuditor's resignation
- AccountsGroup of companies' accounts made up to 31 December 2025
- DirectorsTermination of appointment of Sabera Nazneen Rahman as a director on 9 April 2026
- FilingInformation not on the register a AD02 was removed on 19/12/2025 as it is no longer considered to form part of the register.
- AddressRegister inspection address has been changed (and 1 more like it since 1 December 2022)
- AddressRegister(s) moved to registered inspection location (and 2 more like it since 1 December 2022)
- FilingNotice of Restriction on the Company's Articles
- FilingMemorandum and Articles of Association (and 1 more like it since 27 May 2023)
17 earlier
- NameSecond filed SH01 - 25/04/25 Statement of Capital usd 387659483 25/04/25 Statement of Capital gbp 50000
- DirectorsAppointment of Matthew Shaun Bowden as a secretary on 1 May 2025
- DirectorsTermination of appointment of Adrian Charles Noel Kemp as a secretary on 1 May 2025
- AccountsGroup of companies' accounts made up to 31 December 2024
- DirectorsAppointment of Karen Elizabeth Knudsen Costello as a director on 11 April 2025
- DirectorsTermination of appointment of Andreas Rummelt as a director on 11 April 2025
- DirectorsTermination of appointment of Deborah Disanzo Eldracher as a director on 11 April 2025
- DirectorsAppointment of Birgit Conix as a director on 1 February 2025
- DirectorsAppointment of Rene Anthony Andrada Haas as a director on 1 January 2025
- DirectorsDirector's details changed for Aradhana Sarin on 22 August 2024
- DirectorsDirector's details changed for Diana Louise Patricia Layfield on 21 August 2024
- AccountsGroup of companies' accounts made up to 31 December 2023
- DirectorsDirector's details changed for Marcus Wallenberg on 15 September 2023
- DirectorsDirector's details changed for Marcus Wallenberg on 14 September 2023
- DirectorsAppointment of Anna Olive Magdelene Manz as a director on 1 September 2023
- AccountsGroup of companies' accounts made up to 31 December 2022
- DirectorsTermination of appointment of Leif Valdemar Johansson as a director on 27 April 2023
- Name
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does AstraZeneca do?
Public limited company registered in Cambridge, classed under “Manufacture of basic pharmaceutical products” and 3 other activities. In its own words: “AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.”
›How much turnover does AstraZeneca make?
Answered in the full report
›Is AstraZeneca profitable?
Yes: it made a profit after tax of $10.2bn in the year to 31 December 2025, its latest filed accounts.
›Who runs and owns AstraZeneca?
Answered in the full report
›Where is AstraZeneca based?
Its registered office is 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, in Cambridge.
›When was AstraZeneca founded?
Astrazeneca PLC was incorporated on 17 June 1992.
›Is AstraZeneca still trading?
The register lists Astrazeneca PLC as active.